EHEmran Hossen

Emran Hossen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emran Hossen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Imaging‐derived coronary fractional flow reserve: advances in physics‐based, machine learning, and physics‐informed methods

    by Tanxin Zhu, Emran Hossen, Chen Zhao, Jingfeng Jiang, Michele Esposito, Jiguang Sun, Weihua Zhou

    Objective . To provide a translation-oriented review of imaging-derived coronary fractional flow reserve (FFR) methods for functional assessment of coronary artery stenosis, with emphasis on computed tomography coronary angiography- and invasive coronary angiography-based workflows. Approach . We synthesize recent developments in physics-based computational fluid dynamics (CFD), reduced-order modeling, machine learning/deep learning (ML/DL), and physics-informed learning, including physics-informed neural networks (PINNs) and neural operators. The review is organized around clinical workflow requirements, computational feasibility, image-quality constraints, boundary-condition uncertainty, model validation, and deployment-oriented evaluation. Main results . Physics-based FFR methods provide mechanistic interpretability and spatially resolved hemodynamics, but remain sensitive to coronary geometry, physiological assumptions, and computational burden. ML/DL approaches markedly accelerate FFR estimation, but their reliability depends on representative data, calibration, and robustness to domain shift. Among emerging approaches, physics-informed learning currently offers a favorable methodological balance of computational speed, physical consistency, data efficiency, and spatially resolved output. Complementary coronary studies support this assessment: graph-based physics-informed learning has shown strong agreement with measured FFR across x-ray and CT data; a physics-informed operator preserved near-CFD/PINN diagnostic performance while reducing inference from hundreds of seconds to less than one second; and physics-informed pretraining improved a downstream clinical prediction task while producing pressure and FFR curves. The latter finding supports transferable physiological representation learning rather than direct validation of FFR accuracy against invasive pressure-wire measurements. Overall, these results support physics-informed methods as a promising next-generation research direction, although prospective multicenter validation remains necessary. Significance . Imaging-derived FFR is moving toward faster, more automated, and more physiologically constrained decision support. Among emerging computational paradigms, physics-informed models are particularly promising because they can retain the speed of learned inference while constraining predictions with governing equations and boundary conditions. Current comparative evidence supports prioritizing these methods for prospective clinical validation, with their apparent advantages tested against established CFD, data-driven ML, and invasive physiological references.

  • A robust optimal control framework for controlling aberrant RTK signaling pathways in esophageal cancer

    by Souvik Roy, Zui Pan, Naif Abu Qarnayn, Mesfer Alajmi, Ali Alatawi, Asma Alghamdi, Ibrahem Alshaoosh, Zahra Asiri, Berlinda Batista, Shreshtha Chaturvedi, et al.

    This study presents a new framework for obtaining personalized optimal treatment strategies targeting aberrant signaling pathways in esophageal cancer, such as the epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) signaling pathways. A new pharmacokinetic model is developed taking into account specific heterogeneities of these signaling mechanisms. The optimal therapies are designed to be obtained using a three step process. First, a finite-dimensional constrained optimization problem is solved to obtain the parameters of the pharmacokinetic model, using discrete patient data measurements. Next, a sensitivity analysis is carried out to determine which of the parameters are sensitive to the evolution of the variants of EGF receptors and VEGF receptors. Finally, a second optimal control problem is solved based on the sensitivity analysis results, using a modified pharmacokinetic model that incorporates two representative drugs Trastuzumab and Bevacizumab, targeting EGF and VEGF, respectively. Numerical results with the combination of the two drugs demonstrate the efficiency of the proposed framework.


  • Open Access

    Phosphorylation of Shank3 by Rho-Kinase regulates surface translocation of NMDA and AMPA receptors in PSD

    by Rijwan Uddin Ahammad, Yasuhiro Funahashi, Omar Faruk, Emran Hossen, Kozo Kaibuchi.

    The small GTPase RhoA and its downstream effector Rho-kinase (Rock) are considered as one of the key regulators in dendritic spine formation and synaptic plasticity. However, how RhoA/Rho-kinase signaling involved in modulating synaptic plasticity still remains unknown. In the excitatory synapses, postsynaptic density (PSD) located usually at the tip of dendritic spine containing glutamate receptors and other membrane bound scaffold proteins plays role in synaptic plasticity, but how they are regulated and what are the upstream signaling is not clearly understood yet. We have recently developed a phosphoproteomic analysis method that uses affinity beads coated with 14-3-3 proteins to enrich phosphorylated proteins and established the kinase-associated neural phosphosignaling (KANPHOS) database that provides the phosphorylated sites identified by our phosphoproteomic approaches (Nagai et al, Neuron, 2016; Nagai et al, Trends Pharmacol Sci, 2016). In this study, using our KANPHOS database, we identified Shank3, which is adapter protein of AMPA and NMDA receptors in PSD, as a novel Rho-kinase substrate. We also found that Shank3 interacted with 14-3-3 and this interaction was regulated by Rho-kinase. Phospho-deficient mutants of Shank3 (T551A, S694A and S781A) reduced its interaction with 14-3-3. To monitor the in vivo phosphorylation state of Shank3, we prepared antibodies that specifically recognized phosphorylated Shank3, and we identified Rho-Kinase phosphorylated Shank3 at T551, S694 and S781 in mouse neostriatum slice culture. Furthermore, NMDA activated Rho-kinase through CaMKII in striatal slices, which phosphorylated Shank3 and increased interaction of Shank3 with 14-3-3. Finally, we identified that NMDA-induced Rho-kinase activation increased the interaction of Shank3 with NMDA and AMPA receptors. These results indicate that the phosphorylation of Shank3 by Rho-kinase regulates its interaction with 14-3-3. This phosphorylation may regulate surface translocation of NMDA and AMPA receptors in PSD to orchestrate synaptic plasticity.